RCOR1.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description|
22 22
|:------:|:----:|--------------------------------------|
23
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016b]|
23
+|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016]|
24 24
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
REV3L.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|--------------------------------------|
20
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022b]|
20
+|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
RHOA.md
... ...
@@ -23,8 +23,8 @@ timeline
23 23
|Entity|Tier|Description |
24 24
|:------:|:----:|--------------------------|
25 25
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
26
-|![BL](images/icons/BL_tier1.png) |1 |high-confidence BL gene [@richterRecurrentMutationID32012a]|
27
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@zhangGeneticHeterogeneityDiffuse2013; @reddyGeneticFunctionalDrivers2017; @chapuyMolecularSubtypesDiffuse2018b]|
26
+|![BL](images/icons/BL_tier1.png) |1 |high-confidence BL gene [@richterRecurrentMutationID32012]|
27
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@zhangGeneticHeterogeneityDiffuse2013; @reddyGeneticFunctionalDrivers2017; @chapuyMolecularSubtypesDiffuse2018]|
28 28
29 29
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
30 30
RPL1L.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description|
22 22
|:------:|:----:|--------------------------------------|
23
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016b]|
23
+|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@spinaGeneticsNodalMarginal2016]|
24 24
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
SAL3.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|--------------------------------------|
20
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022b]|
20
+|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
SHROOM3.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|--------------------------------------|
20
-|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023b]|
20
+|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
SRRM2.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
|Entity|Tier|Description |
20 20
|:------:|:----:|-----------------------------------------|
21 21
|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@morinMutationalStructuralAnalysis2013]|
22
-|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established [@russler-germainMutationsAssociatedProgression2023b]|
22
+|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established [@russler-germainMutationsAssociatedProgression2023]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
TERT.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|------------------------|
20
-|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene[@nadeuGenomicEpigenomicInsights2020b]|
20
+|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene[@nadeuGenomicEpigenomicInsights2020]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
VMA21.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|-----------------------|
20
-|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene[@hubschmannMutationalMechanismsShaping2021b]|
20
+|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene[@hubschmannMutationalMechanismsShaping2021]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
ZCCHC11.md
... ...
@@ -20,7 +20,7 @@ timeline
20 20
21 21
|Entity|Tier|Description|
22 22
|:------:|:----:|--------------------------------------|
23
-|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@tiacciPervasiveMutationsJAKSTAT2018b]|
23
+|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@tiacciPervasiveMutationsJAKSTAT2018]|
24 24
25 25
26 26
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
ZNF217.md
... ...
@@ -18,8 +18,8 @@ timeline
18 18
19 19
|Entity|Tier|Description |
20 20
|:------:|:----:|-----------------------------------------|
21
-|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@reichelFlowSortingExome2015a]|
22
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021b]|
21
+|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@reichelFlowSortingExome2015]|
22
+|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@hubschmannMutationalMechanismsShaping2021]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
ZNF292.md
... ...
@@ -18,7 +18,7 @@ timeline
18 18
19 19
|Entity|Tier|Description |
20 20
|:------:|:----:|--------------------------|
21
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@reddyGeneticFunctionalDrivers2017; @hubschmannMutationalMechanismsShaping2021b]|
21
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@reddyGeneticFunctionalDrivers2017; @hubschmannMutationalMechanismsShaping2021]|
22 22
23 23
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
24 24
ZNF423.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|-----------------------------------------|
20
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@chapuyMolecularSubtypesDiffuse2018b]|
20
+|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@chapuyMolecularSubtypesDiffuse2018]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
ZNF608.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------|
22
-|![FL](images/icons/FL_tier2.png)|2|relevance in FL not firmly established[@krysiakRecurrentSomaticMutations2017b]|
22
+|![FL](images/icons/FL_tier2.png)|2|relevance in FL not firmly established[@krysiakRecurrentSomaticMutations2017]|
23 23
|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene[@morinMutationalStructuralAnalysis2013; @reddyGeneticFunctionalDrivers2017]|
24 24
25 25
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
ZNF85.md
... ...
@@ -17,7 +17,7 @@ timeline
17 17
18 18
|Entity|Tier|Description |
19 19
|:------:|:----:|--------------------------------------|
20
-|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022b]|
20
+|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@burkhardtClinicalRelevanceMolecular2022]|
21 21
22 22
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 23
ashm.md
... ...
@@ -45,8 +45,8 @@
45 45
|[FOXP1_TSS-2](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71350633%2D71357665)|chr3:71350633-71357665|3.77|0.65|0.94|3.47|
46 46
|[FOXP1_TSS-3](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71176427%2D71180960)|chr3:71176427-71180960|10.98|2.38|4.69|2.7|
47 47
|[FOXP1_TSS-4](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71104986%2D71119518)|chr3:71104986-71119518|14.43|1.94|0|6.95|
48
-|[FOXP1_intron-1a](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71550753%2D71551478)|chr3:71550753-71551478|5.9|3.46|0.47|6.56|
49
-|[FOXP1_intron-1b](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71503103%2D71504870)|chr3:71503103-71504870|2.46|3.24|0.94|1.93|
48
+|[FOXP1_intron-1A](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71550753%2D71551478)|chr3:71550753-71551478|5.9|3.46|0.47|6.56|
49
+|[FOXP1_intron-1B](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr3%3A71503103%2D71504870)|chr3:71503103-71504870|2.46|3.24|0.94|1.93|
50 50
|[GRHPR_TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr9%3A37423010%2D37425279)|chr9:37423010-37425279|14.1|1.3|0|0.77|
51 51
|[HNRNPU_TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A245023502%2D245029083)|chr1:245023502-245029083|3.77|3.67|0.47|8.88|
52 52
|[ID3_TSS](https://genome.ucsc.edu/s/rdmorin/GAMBL%20hg19?position=chr1%3A23885584%2D23885835)|chr1:23885584-23885835|1.48|0.65|0|46.33|